Metabolic Bone Unit, Department of Internal Medicine, University of Florence, Florence, Italy.
PLoS One. 2012;7(6):e39767. doi: 10.1371/journal.pone.0039767. Epub 2012 Jun 27.
Multiple endocrine neoplasia type 1 (MEN1) syndrome is a rare hereditary cancer disorder characterized by tumors of the parathyroids, of the neuroendocrine cells, of the gastro-entero-pancreatic tract, of the anterior pituitary, and by non-endocrine neoplasms and lesions. MEN1 gene, a tumor suppressor gene, encodes menin protein. Loss of heterozygosity at 11q13 is typical of MEN1 tumors, in agreement with the Knudson's two-hit hypothesis. In silico analysis with Target Scan, Miranda and Pictar-Vert softwares for the prediction of miRNA targets indicated miR-24-1 as capable to bind to the 3'UTR of MEN1 mRNA. We investigated this possibility by analysis of miR-24-1 expression profiles in parathyroid adenomatous tissues from MEN1 gene mutation carriers, in their sporadic non-MEN1 counterparts, and in normal parathyroid tissue. Interestingly, the MEN1 tumorigenesis seems to be under the control of a "negative feedback loop" between miR-24-1 and menin protein, that mimics the second hit of Knudson's hypothesis and that could buffer the effect of the stochastic factors that contribute to the onset and progression of this disease. Our data show an alternative way to MEN1 tumorigenesis and, probably, to the "two-hit dogma". The functional significance of this regulatory mechanism in MEN1 tumorigenesis is also the basis for opening future developments of RNA antagomir(s)-based strategies in the in vivo control of tumorigenesis in MEN1 carriers.
多发性内分泌腺瘤病 1 型(MEN1)综合征是一种罕见的遗传性癌症疾病,其特征为甲状旁腺、神经内分泌细胞、胃肠胰消化道、垂体前叶的肿瘤,以及非内分泌肿瘤和病变。MEN1 基因是一种肿瘤抑制基因,编码 menin 蛋白。11q13 的杂合性缺失是 MEN1 肿瘤的典型特征,与 Knudson 的两次打击假说一致。Target Scan、Miranda 和 Pictar-Vert 软件的计算机分析用于预测 miRNA 靶标,表明 miR-24-1 能够与 MEN1 mRNA 的 3'UTR 结合。我们通过分析 MEN1 基因突变携带者、散发性非 MEN1 对照者和正常甲状旁腺组织中甲状旁腺瘤组织中的 miR-24-1 表达谱来研究这种可能性。有趣的是,MEN1 肿瘤发生似乎受到 miR-24-1 和 menin 蛋白之间“负反馈环”的控制,这种控制模拟了 Knudson 假说的第二次打击,并且可以缓冲导致这种疾病发生和进展的随机因素的影响。我们的数据显示了 MEN1 肿瘤发生的另一种方式,可能还有“两次打击假说”。这种调控机制在 MEN1 肿瘤发生中的功能意义也是基于 MEN1 携带者体内肿瘤发生的 RNA 拮抗物(s)的基于策略的未来发展的基础。